Targeting Inflammasome Activation in Viral Infection: A Therapeutic Solution?


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
27 06 2023
Historique:
received: 26 05 2023
revised: 24 06 2023
accepted: 26 06 2023
medline: 31 7 2023
pubmed: 29 7 2023
entrez: 29 7 2023
Statut: epublish

Résumé

Inflammasome activation is exclusively involved in sensing activation of innate immunity and inflammatory response during viral infection. Accumulating evidence suggests that the manipulation of inflammasome assembly or its interaction with viral proteins are critical factors in viral pathogenesis. Results from pilot clinical trials show encouraging results of NLRP3 inflammasome suppression in reducing mortality and morbidity in SARS-CoV-2-infected patients. In this article, we summarize the up-to-date understanding of inflammasomes, including NLRP3, AIM2, NLRP1, NLRP6, and NLRC4 in various viral infections, with particular focus on RNA viruses such as SARS-CoV-2, HIV, IAV, and Zika virus and DNA viruses such as herpes simplex virus 1. We also discuss the current achievement of the mechanisms involved in viral infection-induced inflammatory response, host defense, and possible therapeutic solutions.

Identifiants

pubmed: 37515138
pii: v15071451
doi: 10.3390/v15071451
pmc: PMC10384481
pii:
doi:

Substances chimiques

Inflammasomes 0
NLR Family, Pyrin Domain-Containing 3 Protein 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Cell. 2023 Jun 22;186(13):2783-2801.e20
pubmed: 37267949
Nat Commun. 2018 Apr 19;9(1):1560
pubmed: 29674674
Nat Metab. 2021 Aug;3(8):1109-1124
pubmed: 34385701
Cell Host Microbe. 2023 Feb 8;31(2):243-259.e6
pubmed: 36563691
Nat Commun. 2020 Jan 9;11(1):147
pubmed: 31919342
Proc Natl Acad Sci U S A. 2021 Sep 14;118(37):
pubmed: 34497121
BMJ Support Palliat Care. 2021 Jun 25;:
pubmed: 34172507
Biochem Biophys Res Commun. 2018 Sep 5;503(2):436-443
pubmed: 29655793
Nat Med. 2018 Aug;24(8):1151-1156
pubmed: 29967349
J Immunol. 2015 May 15;194(10):4880-90
pubmed: 25847972
Hong Kong Med J. 2021 Jun;27 Suppl 2(3):33-35
pubmed: 34075889
Science. 2020 Sep 25;369(6511):1633-1637
pubmed: 32820063
Sci Immunol. 2020 Oct 2;5(52):
pubmed: 33008915
ACS Chem Biol. 2022 Sep 16;17(9):2595-2604
pubmed: 36044633
PLoS Pathog. 2021 Feb 1;17(2):e1009285
pubmed: 33524073
J Exp Med. 2005 May 2;201(9):1479-86
pubmed: 15851489
BMC Med. 2022 Sep 5;20(1):279
pubmed: 36058909
Nature. 2021 Sep;597(7876):415-419
pubmed: 34471287
Sci Adv. 2022 Sep 16;8(37):eabo5400
pubmed: 36103544
EClinicalMedicine. 2022 Sep 17;53:101649
pubmed: 36128334
Cell. 2021 Nov 11;184(23):5759-5774.e20
pubmed: 34678144
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Blood Adv. 2022 Apr 12;6(7):2001-2013
pubmed: 34991159
J Immunol. 2018 Feb 1;200(3):1188-1197
pubmed: 29282312
Nature. 2022 Jun;606(7914):576-584
pubmed: 35385861
Cell Host Microbe. 2019 Apr 10;25(4):602-616.e7
pubmed: 30902577
Science. 2014 Nov 14;346(6211):861-5
pubmed: 25395539
J Clin Invest. 2019 Apr 30;129(7):2888-2897
pubmed: 31038471
Sci Adv. 2022 Sep 16;8(37):eabo0732
pubmed: 36112681
Cell. 2023 May 11;186(10):2144-2159.e22
pubmed: 37172565
Proc Natl Acad Sci U S A. 2020 Jan 21;117(3):1722-1730
pubmed: 31919284
Cell Res. 2021 Mar;31(3):272-290
pubmed: 33473155
Proc Natl Acad Sci U S A. 2023 Jun 20;120(25):e2304445120
pubmed: 37307479
Nat Chem Biol. 2023 Apr;19(4):431-439
pubmed: 36357533
Sci Immunol. 2022 Aug 26;7(74):eabo6294
pubmed: 35587515
Nat Commun. 2016 Dec 08;7:13727
pubmed: 27929086
Cell. 2020 Mar 19;180(6):1044-1066
pubmed: 32164908
Nature. 2018 Dec;564(7734):71-76
pubmed: 30487600
Sci Rep. 2016 Jun 10;6:27912
pubmed: 27283237
EBioMedicine. 2022 Nov;85:104299
pubmed: 36209522
Cell Host Microbe. 2018 Feb 14;23(2):254-265.e7
pubmed: 29447697
EMBO J. 2020 Oct 1;39(19):e105071
pubmed: 32840892
mBio. 2022 Jan 18;13(1):e0173721
pubmed: 35038917
Viruses. 2023 Jan 24;15(2):
pubmed: 36851549
J Biol Chem. 2021 Jan-Jun;296:100579
pubmed: 33766561
EMBO J. 2021 Sep 15;40(18):e108249
pubmed: 34296442
Nat Commun. 2021 Aug 2;12(1):4664
pubmed: 34341353
Immunity. 2022 Dec 13;55(12):2271-2284.e7
pubmed: 36384135
Cell Metab. 2021 Jan 5;33(1):65-77.e2
pubmed: 33248471
Cell. 2023 May 25;186(11):2288-2312
pubmed: 37236155
PLoS One. 2022 Apr 21;17(4):e0257408
pubmed: 35446851
Cell. 2022 Jun 28;:
pubmed: 35777355
Hepatology. 2022 Jan;75(1):196-212
pubmed: 34392558
Virology. 2022 Mar;568:13-22
pubmed: 35066302
Nat Rev Immunol. 2022 Jan;22(1):47-56
pubmed: 34837062
Infection. 2023 Jun;51(3):641-654
pubmed: 36104613
Acta Pharmacol Sin. 2023 Aug;44(8):1637-1648
pubmed: 36882503
Mol Cell. 2022 Jul 7;82(13):2385-2400.e9
pubmed: 35594856
Elife. 2021 Jun 21;10:
pubmed: 34151773
Viruses. 2022 May 09;14(5):
pubmed: 35632746
PLoS Pathog. 2021 Apr 16;17(4):e1009417
pubmed: 33861800
Mol Cell. 2015 Sep 17;59(6):941-55
pubmed: 26384664
Sci Rep. 2022 Nov 14;12(1):19528
pubmed: 36376416
Nat Immunol. 2023 Jan;24(1):30-41
pubmed: 36443515
Nat Commun. 2023 Feb 6;14(1):642
pubmed: 36746963
mBio. 2022 Jun 28;13(3):e0095122
pubmed: 35587188
Sci Immunol. 2019 Oct 25;4(40):
pubmed: 31653718
Am Heart J Plus. 2023 Aug;32:100305
pubmed: 37337595
Cell. 2020 Apr 30;181(3):674-687.e13
pubmed: 32298652
Cell Death Differ. 2022 Jun;29(6):1240-1254
pubmed: 34997207
PLoS Pathog. 2022 Apr 4;18(4):e1010416
pubmed: 35377924
Nat Commun. 2023 Apr 22;14(1):2329
pubmed: 37087523
Nature. 2021 Mar;591(7849):300-305
pubmed: 33505023
mBio. 2023 Apr 25;14(2):e0011023
pubmed: 36852999
J Virol. 2023 Mar 30;97(3):e0000323
pubmed: 36877049
J Virol. 2022 May 25;96(10):e0030922
pubmed: 35502911
Front Microbiol. 2022 Mar 21;13:838808
pubmed: 35387080
PLoS Pathog. 2022 Aug 26;18(8):e1010787
pubmed: 36026486
Science. 2011 Jan 21;331(6015):330-4
pubmed: 21252346
J Virol. 2022 Jul 27;96(14):e0212721
pubmed: 35758658
J Virol. 2023 Feb 28;97(2):e0122722
pubmed: 36656014
Mol Cell. 2002 Aug;10(2):417-26
pubmed: 12191486
EBioMedicine. 2021 Apr;66:103339
pubmed: 33867313
Biomed Pharmacother. 2021 Jun;138:111442
pubmed: 33667791
J Neurol. 2023 May;270(5):2380-2391
pubmed: 36933032
Nat Commun. 2018 Aug 1;9(1):3001
pubmed: 30069026
N Engl J Med. 2016 May 19;374(20):1981-7
pubmed: 27074377
Cell. 2006 Aug 25;126(4):659-62
pubmed: 16923387
Hepatology. 2022 Dec;76(6):1563-1575
pubmed: 35596929
Eur J Immunol. 2016 Feb;46(2):269-80
pubmed: 26626159
Immunology. 2021 Mar;162(3):281-289
pubmed: 33314083
Science. 2015 Nov 13;350(6262):826-30
pubmed: 26494172
PLoS Pathog. 2020 Mar 18;16(3):e1008335
pubmed: 32187211
Trends Biochem Sci. 2018 Sep;43(9):685-699
pubmed: 30049633
Cell. 2020 May 28;181(5):1036-1045.e9
pubmed: 32416070
Br J Pharmacol. 2019 Oct;176(19):3834-3844
pubmed: 31271646
EMBO Mol Med. 2021 Aug 9;13(8):e14150
pubmed: 34133077
Viruses. 2023 Jan 17;15(2):
pubmed: 36851476
Lancet Gastroenterol Hepatol. 2023 Feb;8(2):145-156
pubmed: 36481043
Nat Immunol. 2022 Feb;23(2):165-176
pubmed: 35105981
Immunity. 2021 Jul 13;54(7):1463-1477.e11
pubmed: 34115964
FASEB J. 2019 Aug;33(8):8865-8877
pubmed: 31034780
RNA Biol. 2020 Mar;17(3):335-349
pubmed: 31840571
J Virol. 2014 Oct;88(19):11229-39
pubmed: 25031336
PLoS Pathog. 2019 Sep 3;15(9):e1007934
pubmed: 31479495
Viruses. 2022 Jan 05;14(1):
pubmed: 35062292
Nature. 2017 Jun 29;546(7660):667-670
pubmed: 28636595
PLoS Biol. 2023 Jun 8;21(6):e3002144
pubmed: 37289745
Mol Cell. 2017 Oct 5;68(1):185-197.e6
pubmed: 28943315
Science. 2021 Jan 29;371(6528):
pubmed: 33243852
Nat Immunol. 2020 Oct;21(10):1146-1151
pubmed: 32855555
Crit Care. 2022 Jul 7;26(1):206
pubmed: 35799268
PLoS Pathog. 2018 Nov 13;14(11):e1007428
pubmed: 30422993
EBioMedicine. 2022 Jan;75:103803
pubmed: 34979342
Cell. 2021 Jan 7;184(1):149-168.e17
pubmed: 33278357
Science. 2021 Mar 19;371(6535):
pubmed: 33542150
Nat Immunol. 2023 Apr;24(4):595-603
pubmed: 36941400
Elife. 2023 Feb 17;12:
pubmed: 36800238
Nat Immunol. 2020 Jul;21(7):736-745
pubmed: 32367036
Cell Death Dis. 2022 Mar 25;13(3):269
pubmed: 35338116
Cell. 2015 Apr 9;161(2):333-47
pubmed: 25860612
Cell Rep. 2020 Mar 31;30(13):4370-4385.e7
pubmed: 32234474
J Clin Invest. 2021 Mar 15;131(6):
pubmed: 33720048
J Exp Med. 2017 Aug 7;214(8):2217-2229
pubmed: 28634194
J Virol. 2022 Mar 23;96(6):e0185021
pubmed: 35080426

Auteurs

Chuan-Han Deng (CH)

State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Avenida da Universidade, Taipa, Macao 999078, China.

Tian-Qi Li (TQ)

State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Avenida da Universidade, Taipa, Macao 999078, China.

Wei Zhang (W)

State Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology, Av. Wai Long, Taipa, Macao 999078, China.

Qi Zhao (Q)

Cancer Centre, Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Taipa, Macau 999078, China.
MoE Frontiers Science Center for Precision Oncology, University of Macau, Avenida da Universidade, Taipa, Macao 999078, China.

Ying Wang (Y)

State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Avenida da Universidade, Taipa, Macao 999078, China.
MoE Frontiers Science Center for Precision Oncology, University of Macau, Avenida da Universidade, Taipa, Macao 999078, China.
Department of Pharmaceutical Sciences, Faculty of Health Science, University of Macau, Avenida da Universidade, Taipa, Macao 999078, China.
Minister of Education Key Laboratory of Tumor Molecular Biology, Jinan University, Guangzhou 510632, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH